BioIntegral Surgical
- Company typePrivate
- Founded2019
- HeadquartersMississauga, Canada
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
BioIntegral Surgical firmographics
Firmographics- Name
- BioIntegral Surgical
- Legal name
- BioIntegral Surgical Inc.
- Website
- https://biointegral-surgical.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
BioIntegral Surgical industry classification
Industry- Product category
- Cardiovascular Implants
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Cardiac Surgery Devices (Cannulas, Clamps, Closure, Grafts) (HLAHAFAH)
- akta.pro secondary industry
- Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials) (HLAAAGAB)
Keywords
Where BioIntegral Surgical is headquartered
LocationHeadquarters
- HQ city
- Mississauga
- HQ country
- Canada
- HQ region
- North America
Markets served
BioIntegral Surgical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Others
Marketing channels1 record
BioIntegral Surgical product offering
Product offeringCore offering
BioIntegral Surgical Inc. researches and manufactures all-biological cardiovascular implants intended for critical care pediatric and adult patients. The implants are designed to balance durable designs, quick implantation, and biocompatible materials, while applying overkill sterility methods aimed at eliminating the compromises and shortcomings of alternative cardiovascular implant products.
Product overview
BioIntegral Surgical Inc. offers all-biological cardiovascular implants designed for critical care pediatric and adult patients. The company focuses on developing devices that balance durable designs, quick implantation, and biocompatible materials while aiming to enhance patient outcomes and reduce complications. The source material does not enumerate specific named products or modules - only the general category of cardiovascular implants is mentioned.
Differentiator
Problem solved
Functional benefit
Companies that use BioIntegral Surgical
Customer profileSegments2 records
Ideal customer profiles1 record
BioIntegral Surgical technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
BioIntegral Surgical partnerships and signals
Strategic signalScale indicators1 record
Recent moves4 records
Expansion highlights1 record
BioIntegral Surgical competitors and assessment
Company assessmentEmerging players
- Labcor Laboratórios Ltda: Labcor is a Brazil-based manufacturer of biologic heart valves and vascular grafts, an emerging player focused on tissue-engineered cardiac implants that competes with BioIntegral's all-biological positioning.
Broad incumbents
- Getinge (Cardiac Surgery): Getinge offers a broad portfolio of cardiac surgery and perfusion products including vascular grafts, a broad incumbent serving the same cardiac surgery customer base as BioIntegral.
- Boston Scientific (Cardiovascular): Boston Scientific's cardiovascular division covers structural heart and heart failure devices, a broad incumbent competing with newer entrants like BioIntegral in surgical implant indications.
- Medtronic: Medtronic's Cardiac Surgery division offers heart valves, surgical ablation, and cannulae/grafts used in cardiac surgery — a broad incumbent with overlapping cardiovascular implant capabilities to BioIntegral Surgical.
- Edwards Lifesciences: Edwards Lifesciences is a global leader in heart valves and critical care cardiovascular devices, an established incumbent with broader portfolio but overlapping surgical implant focus to BioIntegral Surgical.
- LivaNova (Cardiac Surgery): LivaNova's Cardiac Surgery business produces heart valves, cannulae, and surgical accessories used in cardiac surgery, an established player whose portfolio intersects BioIntegral's biologic implant focus.
- Abbott (Cardiovascular): Abbott's cardiovascular portfolio spans heart valves, vessel closure, and structural heart devices; a broad incumbent with overlapping cardiac implant categories where BioIntegral Surgical operates.
Direct peers
- W. L. Gore & Associates (Gore Medical): Gore Medical is the leading manufacturer of expanded ePTFE vascular grafts and stent-grafts, a direct peer in biologic/synthetic cardiovascular graft implants used in cardiac and vascular surgery.
- Artivion (formerly CryoLife): Artivion is a tissue-based and mechanical cardiovascular implant company (heart valves, vascular grafts, patches), directly comparable to BioIntegral's focus on all-biological cardiovascular implants for cardiac surgery.
- Terumo Cardiovascular: Terumo Cardiovascular supplies a full line of products for cardiopulmonary bypass and cardiac surgery including vascular grafts and patches, directly comparable to BioIntegral's biologic cardiovascular implants.
Market position
Strengths3 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights5 records
Customer concentration
BioIntegral Surgical social profiles
Digital presenceBioIntegral Surgical financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioIntegral Surgical leadership team
Management profileNumber of profiles
BioIntegral Surgical funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioIntegral Surgical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioIntegral Surgical
What does BioIntegral Surgical do?
BioIntegral Surgical Inc. researches and manufactures all-biological cardiovascular implants intended for critical care pediatric and adult patients. The implants are designed to balance durable designs, quick implantation, and biocompatible materials, while applying overkill sterility methods aimed at eliminating the compromises and shortcomings of alternative cardiovascular implant products.
Is BioIntegral Surgical a public or private company?
BioIntegral Surgical is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was BioIntegral Surgical founded?
BioIntegral Surgical was founded in 2019. It employs 11 to 50 people.
Where is BioIntegral Surgical based?
BioIntegral Surgical is headquartered in Mississauga, Canada, in the North America region.
Who are BioIntegral Surgical's main competitors?
Labcor Laboratórios Ltda is listed as an emerging player. Broad incumbents are Getinge (Cardiac Surgery), Boston Scientific (Cardiovascular), Medtronic, Edwards Lifesciences, LivaNova (Cardiac Surgery) and Abbott (Cardiovascular). Direct peers are W. L. Gore & Associates (Gore Medical), Artivion (formerly CryoLife) and Terumo Cardiovascular.
Does BioIntegral Surgical have an API?
No public API is recorded for BioIntegral Surgical.
What industry is BioIntegral Surgical in?
BioIntegral Surgical's product category is Cardiovascular Implants. Its primary akta.pro industry code is HLAHAFAH, Cardiac Surgery Devices (Cannulas, Clamps, Closure, Grafts), with a secondary code of HLAAAGAB, Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials). Its NAICS code is 339113 and its SIC code is 3842.